Indravadan Modi
Indravadan Modi (1926–2012) was a prominent Indian industrialist and philanthropist, best known for his significant contributions to the pharmaceutical industry in India. He was the founder of Cadila Pharmaceuticals, one of the largest privately-held pharmaceutical companies in India.
Early Life and Education[edit | edit source]
Indravadan Modi was born in 1926 in the small village of Chansad, located in the Gujarat state of India. He completed his early education in his village before moving to Ahmedabad for higher studies. He graduated with a degree in Pharmacy from L.M. College of Pharmacy, Ahmedabad.
Career[edit | edit source]
After completing his education, Modi started his career in the pharmaceutical industry with a small-scale drug manufacturing unit. In 1951, he co-founded Cadila Laboratories along with his friend and colleague, Ramanbhai Patel. The company initially focused on manufacturing pharmaceutical products for the domestic market.
In 1995, due to differences between the partners, Cadila was split into two separate entities: Cadila Healthcare and Cadila Pharmaceuticals. Modi took over the reins of Cadila Pharmaceuticals and under his leadership, the company expanded its operations globally.
Modi was instrumental in introducing several innovative drug delivery systems and biotechnology-based products. He also played a key role in promoting research and development in the Indian pharmaceutical industry.
Philanthropy[edit | edit source]
Apart from his business ventures, Modi was also known for his philanthropic activities. He established the Indravadan A. Modi Research Foundation to promote research in pharmaceutical sciences. He also set up several educational institutions and hospitals in Gujarat.
Awards and Recognition[edit | edit source]
Modi received numerous awards and accolades for his contributions to the pharmaceutical industry. He was awarded the Padma Bhushan, one of the highest civilian awards in India, in 2005.
Death[edit | edit source]
Indravadan Modi passed away in 2012, leaving behind a legacy of innovation and philanthropy in the pharmaceutical industry.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
